Avoid missing critical information with AI-generated summaries. This four-part Claude prompt extracts non-obvious insights, ...

Quetext AI Summarizer creates short, medium, or long summaries in bullets, reports, paragraphs, or meeting notes, now ...

Last week, during a stop in Nashville on his Take Back Your Health tour, the Health and Human Services secretary brought up the technology between condemning ultra-processed foods and urging Americans ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

From the Department of Bizarre Anomalies: Microsoft has suppressed an unexplained anomaly on its network that was routing traffic destined to example.com—a domain reserved for testing purposes—to a ...

Karandeep Singh Oberoi is a Durham College Journalism and Mass Media graduate who joined the Android Police team in April 2024, after serving as a full-time News Writer at Canadian publication ...

FOXBOROUGH, Mass. — Josh McDaniels flipped on some old Patriots game film as a way of introducing himself and his offensive system to Drake Maye. After his first 12 NFL starts during a promising yet ...

WASHINGTON, DC — December 4, 2025 — PBS and WETA today announced BLACK AND JEWISH AMERICA: AN INTERWOVEN HISTORY, a new four-part docuseries that explores the complex relationship between Black ...

1v1 me at Canuial St. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

When the government shut down for a few weeks in October 2013, then-President Barack Obama made sure to blame conservative Republicans for refusing to pass any short-term spending bill that included ...

The most senior leaders of the U.S. government assembled Sunday in Arizona for what was essentially a Christian revival. That such an event took place in 2025 reflects the historic achievement of ...

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...